1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow AZD 1480: new trials by email Literature Review of AZD 1480 trials Research Report on AZD 1480
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours AZD1480 - Solid Malignancies | Phase 1 | Terminated | AstraZeneca | 72 | 2010-04-01 | 2013-07-22 |
| Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases AZD1480 - Primary Myelofibrosis (PMF), Post-Polycythaemia Vera | Phase 1 | Completed | AstraZeneca | 65 | 2009-05-01 | 2017-04-24 |
Neoplasms (1) · Primary Myelofibrosis (1)
AstraZeneca (2)
United States (2) · France (1)
Becker Hewes, MD (1) · Gregory Curt, MD (1) · Ronald Hoffman, MD (1) · Srdan Verstovsek, MD (1) · Vincent Ribrag, MD (1)